Humana (NYSE:HUM) Trading 0.2% Higher

Humana Inc. (NYSE:HUM)’s stock price shot up 0.2% during trading on Tuesday . The company traded as high as $328.18 and last traded at $325.87. 298,915 shares were traded during trading, a decline of 85% from the average session volume of 1,970,095 shares. The stock had previously closed at $325.30.

Wall Street Analyst Weigh In

A number of research firms have commented on HUM. Argus cut Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Mizuho decreased their price target on Humana from $550.00 to $400.00 and set a “buy” rating on the stock in a report on Friday, January 26th. TheStreet lowered Humana from a “b” rating to a “c+” rating in a research report on Monday, January 8th. TD Cowen cut their price objective on Humana from $427.00 to $396.00 and set a “buy” rating for the company in a research report on Tuesday, April 2nd. Finally, Barclays cut their price objective on Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 2nd. Eleven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, Humana has an average rating of “Hold” and a consensus price target of $454.63.

Humana Trading Down 3.6 %

The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.63. The firm has a market cap of $38.13 billion, a P/E ratio of 15.95, a P/E/G ratio of 1.92 and a beta of 0.45. The company’s 50 day simple moving average is $329.24 and its 200-day simple moving average is $396.94.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.12 by $1.11. The business had revenue of $29.61 billion during the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 2.34% and a return on equity of 19.44%. The firm’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter last year, the firm earned $9.38 earnings per share. As a group, research analysts predict that Humana Inc. will post 16.06 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.12%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio is presently 17.86%.

Insider Activity

In related news, Director Jorge S. Mesquita purchased 545 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was purchased at an average price of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.32% of the company’s stock.

Institutional Trading of Humana

Several institutional investors and hedge funds have recently modified their holdings of the stock. Dorsey & Whitney Trust CO LLC raised its stake in shares of Humana by 2.6% during the third quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock valued at $397,000 after acquiring an additional 21 shares in the last quarter. UMB Bank n.a. raised its stake in Humana by 2.8% in the third quarter. UMB Bank n.a. now owns 805 shares of the insurance provider’s stock worth $392,000 after buying an additional 22 shares in the last quarter. First Financial Corp IN raised its stake in Humana by 7.2% in the fourth quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock worth $157,000 after buying an additional 23 shares in the last quarter. PDS Planning Inc raised its stake in Humana by 4.1% in the third quarter. PDS Planning Inc now owns 609 shares of the insurance provider’s stock worth $296,000 after buying an additional 24 shares in the last quarter. Finally, First Trust Direct Indexing L.P. raised its stake in Humana by 0.8% in the third quarter. First Trust Direct Indexing L.P. now owns 2,926 shares of the insurance provider’s stock worth $1,424,000 after buying an additional 24 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.